The Fama French three factor model is an asset pricing model that explains the differences in returns across diversified stock portfolios using three systematic risk factors: market exposure, company size (small minus big, or SMB), and relative price (high minus low, or HML). Published in 1993 in the Journal of Financial Economics and now carrying nearly 15,000 citations, this paper by Eugene Fama and Kenneth French didn't just refine an existing model — it fundamentally changed how academics and investors think about risk, return, and portfolio construction.

What Is the Fama French Three Factor Model?

Before Fama and French, the dominant framework for understanding expected stock returns was the Capital Asset Pricing Model (CAPM), which said that a stock's expected return was determined by one thing: its market beta. Beta measures how much a stock moves relative to the overall market. Higher beta meant higher expected returns. That was the whole story.

Fama and French argued that story was incomplete. Their three factor model expanded the explanation of expected returns to include two additional factors beyond market beta:

  • SMB (Small Minus Big): The return difference between small-cap stocks and large-cap stocks. Historically, smaller companies have delivered higher average returns than larger ones, above and beyond what their market betas would predict.
  • HML (High Minus Low): The return difference between value stocks (high book-to-market ratio) and growth stocks (low book-to-market ratio). Value stocks — those trading cheaply relative to their accounting value — have historically outperformed growth stocks on average.

Together, these three factors explained roughly 90% of the return differences across diversified stock portfolios in their tests, compared to around 60% explained by CAPM alone. That is a staggering improvement, and it's why this paper still dominates conversations in academic finance and evidence-based investing three decades later.

What Are Risk Factors and Why Do They Matter?

A risk factor in this context is a systematic, undiversifiable source of risk that a broad set of investors is exposed to and sensitive to. Because many investors share sensitivity to these risks, assets that carry more of a particular risk need to offer higher expected returns to attract buyers. That's the compensation mechanism.

Think of it this way: you would demand a higher return to hold a riskier asset, all else equal. Everyone knows stocks are riskier than bonds, so stocks have higher expected returns. The insight from Fama and French is that within stocks, some types are systematically riskier than others — and markets price that risk in through higher expected returns.

Small companies, for example, tend to be more financially fragile, less liquid, and more sensitive to economic downturns than large companies. Value stocks often carry the baggage of financial distress or uncertain futures. These aren't random quirks. They're sources of real economic risk, and investors who bear that risk are compensated for it over time — at least according to the risk-based interpretation of the model.

It's worth noting that not everyone agrees on why these premiums exist. Some researchers argue they reflect genuine risk compensation. Others argue they're the result of persistent mispricing or behavioral biases. Fama and French themselves acknowledge this debate is essentially impossible to resolve definitively due to what's called the joint hypothesis problem — you can't test market efficiency without an asset pricing model, and you can't validate the model without assuming market efficiency.

What Did the CAPM Get Wrong?

The CAPM had three well-documented problems that Fama and French set out to address directly:

  • Small stocks outperformed large stocks by more than their betas could explain.
  • Value stocks outperformed growth stocks by more than their betas could explain.
  • The beta-return relationship was weaker than predicted, with low-beta stocks earning more than the model suggested they should.

These were called anomalies — observations that couldn't be reconciled with the existing asset pricing framework. Under the CAPM, if two companies had the same beta, they should have similar expected returns regardless of their size or valuation. Reality said otherwise, and consistently so.

Fama and French opened their paper with blunt language for an academic work, stating that the cross-section of average returns on US common stocks shows little relation to the market betas of the Sharpe-Lintner asset pricing model. They then built their three factor model to explain what the CAPM was missing.

What Is the Value Premium and Does It Still Exist?

The value premium — the tendency for high book-to-market (value) stocks to outperform low book-to-market (growth) stocks — is one of the most studied and debated phenomena in all of finance. In the Fama French framework, this is captured by the HML factor.

A stock's book-to-market ratio compares the company's accounting (book) value to its market capitalization. High book-to-market stocks are relatively cheap — the market isn't paying much of a premium above their asset values. Low book-to-market (growth) stocks are the opposite: investors are paying a large premium for expected future growth.

Historically, value stocks have delivered higher average returns. Whether this will continue, and by how much, is actively debated. The 2010s were particularly brutal for value investing as growth stocks — especially in technology — dramatically outperformed. But the longer-term historical evidence, combined with economic intuition about why cheaper, often distressed companies should carry a risk premium, keeps the value factor firmly embedded in serious asset pricing models.

Does Active Management Hold Up Against Factor Models?

One of the most practically significant implications of the Fama French model concerns active fund management. A 1968 paper had already shown that actively managed funds generally couldn't beat the market after adjusting for market risk (CAPM alpha). Adding size and value factors to the evaluation only made the case against active management stronger.

If an active manager appears to be outperforming the market, the Fama French model provides a framework to ask: is this genuine skill, or is the manager just holding small-cap and value stocks? In many cases, the answer is the latter. A manager charging a 1% fee for what amounts to a value tilt that you could replicate cheaply through a factor-tilted index fund is not adding value — they're adding cost.

This finding has profound implications. It means that before crediting any fund manager with alpha (excess risk-adjusted returns), you need to account for all known systematic factors, not just market beta. Most active managers, when measured against the three-factor or five-factor model, have negative alpha once fees are deducted.

How Did Fama French Improve on the Original Model?

In 2015, Fama and French updated their foundational work with a five factor model, adding two new factors to the original three:

  • RMW (Robust Minus Weak): The profitability factor. Companies with robust operating profitability tend to outperform companies with weak profitability.
  • CMA (Conservative Minus Aggressive): The investment factor. Companies that grow their assets conservatively tend to outperform those that aggressively invest in new assets.

The five factor model pushed explanatory power up to roughly 95% of return differences between diversified portfolios, solving some residual problems the three factor model couldn't fully address. It's now the workhorse model in academic asset pricing research, though debate continues about which factors are most robust and whether other factors — momentum, quality, low volatility — deserve inclusion.

The explosion of factor research after 1993 became so unwieldy that economist John Cochrane, in his 2011 presidential address to the American Finance Association, famously described the proliferation as a "factor zoo." A 2016 survey found 316 distinct factors had been published in academic journals. Not all of them are worth your attention, but the core Fama French factors have survived decades of scrutiny.

How Can Investors Actually Use Factor Investing?

The practical takeaway from Fama and French's research is that long-term expected returns are driven by systematic exposure to specific factors — and that investors may be able to achieve higher expected returns by deliberately tilting their portfolios toward small-cap and value stocks, as well as highly profitable companies with conservative investment behavior.

This is not about stock picking. It's about building broadly diversified portfolios that are systematically tilted toward factors with long-term evidence behind them, and doing so at low cost.

Fund companies like Dimensional Fund Advisors — where Eugene Fama himself is a founding director — and Avantis Investors have built their entire investment philosophy around implementing this research in real portfolios. These are not traditional index funds, but they're also not active managers trying to pick winning stocks. They're factor-aware, broadly diversified, and built to deliver the premiums that Fama and French identified — at costs far lower than traditional active management.

The evidence supporting factor investing is stronger than almost anything else in empirical finance. That doesn't make it a guarantee. Factor premiums can disappear for years at a time. But for long-term investors who understand what they own and why they own it, the Fama French framework remains one of the most rigorous and practical foundations for building a portfolio that's built on evidence rather than guesswork.